openPR Logo
Press release

Pneumoconiosis Market is Expected to Grow at a CAGR of ~ 4.4 % % by 2023

11-02-2017 08:22 PM CET | Health & Medicine

Press release from: Market Research Future

Pneumoconiosis Market

Pneumoconiosis Market

Market Research Future published a half-cooked research report on global pneumoconiosis market. Which is Expected to Grow at a CAGR of ~ 4.4 % % by 2023
Pneumoconiosis Market Research Report, By Type (Asbestosis, Berylliosis, Byssinosis, Coal Workers Pneumoconiosis, Silicosis), Cause (Organic Dusts, Non-Organic Substances), Therapy (Diagnosis, Treatment), End User (Hospital) - Global Forecast till 2023

The global pneumoconiosis market is expected to grow at a CAGR of 6.8% during forecast period.
Pneumoconiosis occurs when a person inhales particles such as asbestos, coal dust, or silica. Some time it may causes inflammation in the lungs. A number of different factors are responsible for causing pneumoconiosis. Global pneumoconiosis market is majorly driven by the increasing prevalence of pneumoconiosis. According to the Centers for Disease Control and Prevention, in 2013, pneumoconiosis was responsible for 260,000 deaths across the globe. Moreover, increasing pollution, changing lifestyle and increasing geriatric population have fuelled the growth of the market. Smoking increases the possibility of the pneumoconiosis, thereby, the rapidly increasing number of smokers has also contributed in the growth of the market. On the other hand, lack of absolute treatment may restrain the market growth.

Get a Sample report at https://www.marketresearchfuture.com/sample_request/4639 .

Regional Analysis
The Americas dominate the global pneumoconiosis market owing to a large patient population, strong government support for research & development, and high healthcare spending. Smoking increase the risk of causing this disease. According to the Centers for Disease Control and Prevention, in 2015, about 15 in every 100 U.S. adults aged over 18 years smoked cigarettes. Which is estimated around 36.5 million adults in the United States currently smoke cigarettes. Moreover, changing lifestyle and increasing number of smokers has fuelled the growth of the market.
Europe has the second leading market in global pneumoconiosis market which is followed by Asia Pacific. Asia Pacific is the fastest growing market for pneumoconiosis. As per statistics, more than half of the china population smoke. China and India contribute a major share in the Asia Pacific pneumoconiosis market. Increasing geriatric population and increasing air pollution in this region have fuelled the growth of the market.
The Middle East and Africa contribute the least in the growth of global pneumoconiosis market. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition. However the growth of the Africa market is high due to the presence of opportunities for the development of the market.

Get a discount at https://www.marketresearchfuture.com/check-discount/4639 .

Key Players
The key players for the global pneumoconiosis market Abbott (US) Eli Lilly (US), Sunpharma (India), Sanofi (France), Novo Nordisk (Denmark), Novartis (Switzerland), Abbott (US), AstraZeneca (UK), Merck & Co. (U.S.), Pfizer (U.S.), Svizera Healthcare (India), F. Hoffman La Roche AG (Germany), and Bayer Cropscience Ltd. (U.S.).
Segmentation
The global pneumoconiosis market is segmented on the basis of types, causes, therapy, and end users.
On the basis of type, the market is segmented into asbestosis, berylliosis, byssinosis, coal workers pneumoconiosis, silicosis, and others.
On the basis of cause, the market is categorized into organic dusts, non-organic substances, and others. Organic substances are further segmented into hay, malt, mushrooms, and others. Non organic substances are further segmented into sulphur dioxide, ammonia, nitrogen dioxide, and others.
On the basis of therapy, the market is segmented into diagnosis, and treatment. Diagnosis is further segmented into chest X-ray, CT scan, and others. Treatment is further classified into mucolytic agent, antibiotic, and others.
On the basis of end user, the market is segmented into hospital, clinics, and others.

Browse Complete Report at https://www.marketresearchfuture.com/reports/pneumoconiosis-market-4639 .

Pneumoconiosis is a restrictive and occupational lung disease caused by inhalation of dust. There are a number of different agents that, when inhaled, can potentially cause pneumoconiosis. Organic and inorganic agents are responsible for causing this diseases. According to the Centers for Disease Control and Prevention, in 2013, 260,000 deaths occurred due to pneumoconiosis. Increasing prevalence of pneumoconiosis, increasing smoking population, and rising air pollution have driven the growth of the market. Approximately 75% of non-asbestos pneumoconiosis cases recorded under the IIDB scheme in 2009 were from individuals that are over 65 years. According to the Centers for Disease Control and Prevention, cigarette smoking is the leading cause of death in the United States, accounting for over 480,000 deaths every year. Moreover, increasing geriatric population, increasing healthcare expenditure, and strong encouragement from the government have also contributed to the growth of the market.

About us
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@Marketresearchfuture.Com
Web: Https://Www.Marketresearchfuture.Com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pneumoconiosis Market is Expected to Grow at a CAGR of ~ 4.4 % % by 2023 here

News-ID: 799542 • Views:

More Releases from Market Research Future

Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
The Glue Machine Market is witnessing significant growth due to the increasing adoption of adhesive technologies across various industries, including packaging, woodworking, automotive, furniture, and construction. Valued at USD 9.15 billion in 2024, the market is projected to reach USD 14.9 billion by 2035, registering a CAGR of 4.56% between 2025 and 2035. Glue machines, also known as adhesive application machines, are critical for efficiently dispensing adhesives in industrial and commercial
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
The expansion valves market is witnessing steady growth due to increasing demand for efficient heating, ventilation, air conditioning, and refrigeration (HVACR) systems across residential, commercial, and industrial sectors. Valued at USD 3.28 billion in 2024, the market is projected to reach USD 5.39 billion by 2035, growing at a CAGR of 4.62% between 2025 and 2035. Expansion valves, also known as thermostatic expansion valves (TXVs) or electronic expansion valves (EEVs), are
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CAGR
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CA …
The Cheese Packaging Market is poised for steady growth over the next decade due to rising demand for dairy products, evolving consumer preferences, and increasing focus on food safety and sustainability. According to recent estimates, the market was valued at USD 71.87 billion in 2024 and is projected to reach USD 101.31 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.50% between 2025 and 2034. Cheese packaging
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
The Maritime Market is a cornerstone of international trade, logistics, and economic connectivity, serving as the backbone of global commerce. Valued at USD 2,181.1 billion in 2024, the market is projected to expand to USD 2,920 billion by 2035, registering a steady CAGR of 2.69% between 2025 and 2035. Despite modest growth, the industry's scale and importance are unmatched, as more than 80% of global trade volume is carried by

All 5 Releases


More Releases for Pneumoconiosis

Pneumoconiosis Market to Exceed USD 2.3 Billion by 2034.
Pneumoconiosis, a group of occupational lung diseases, results from long-term inhalation of toxic dust such as coal dust, asbestos, silica, and other fine particles. These particles cause chronic inflammation and scarring in the lungs, leading to progressive loss of lung function, shortness of breath, and in severe cases, respiratory failure. The disease is commonly seen in miners, construction workers, and individuals working in industries like textile, metalworking, and shipbuilding. Download Full
Pneumoconiosis Treatment Market Analysis and Future Prospects for 2030
The world of the pneumoconiosis treatment market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing environment.
Pneumoconiosis Market Analysis and Future Prospects for 2030
The world of the pneumoconiosis market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing environment. We
Characteristics of Pneumoconiosis Market Province, China from 2022 to 2029: a de …
When a person breaths in dust particles such as asbestos, coal dust, or silica, pneumoconiosis can develop. If these particles get into the lungs' airways or air sacs, the body will try to fight them off by inflaming them. Because there is currently no cure for pneumoconiosis, treatment focuses on symptom management and preventing the disease from worsening. The treatment plan for this condition include oxygen therapy, bronchodilator, antibiotics and
Coal-Workers' Pneumoconiosis Drug Market By Type, Size, Share, Trends, Growth an …
Data Bridge Market Research analyses that the coal-workers' pneumoconiosis drug will exhibit a CAGR of around 6% for the forecast period of 2021-2028. Rising government policies and initiatives to offer a fund to many research institute and pharmaceuticals companies, increasing prevalence of black lung disease, increasing mining activities and increased expenditure for the development of healthcare infrastructure are the major factors attributable to the growth of coal-workers' pneumoconiosis drug market.
Pneumoconiosis Market Analysis, Epidemiology, Leading Companies, Pipeline Drugs …
Pneumoconiosis is a lung disease that affects miners, builders, and other workers who breathe in certain kinds of dust on the job. Over time, the dust gathers in your lungs, and you may find it hard to get enough air. You may hear other people call pneumoconiosis "black lung disease" or "popcorn lung." There's no cure, but treatments can make it easier for you to breathe and go about your